Lonergan Partners Places CEO at CS-Keys, Inc.

May 6, 2010 – Executive search firm Lonergan Partners has recruited Robert Feeney, Ph.D. as chief executive officer of CS-Keys, Inc. The search was led by Mark Reiff. Dr. Feeney most recently served as vice president of business development for NeoGenomics Laboratories. “We were pleased to work with the investors, founders, and the board of CS-Keys. Their commitment to commercialize a product for pathologists that is highly accurate and easy to use for the confirmation of hard to diagnose cancers is a potential game-changer,” said Mr. Reiff. “With Rob’s background of lab experience, a Ph.D. in cellular biology, and hands-on experience in this space, he was a perfect fit for the future of CS-Keys.” CS-Keys is a private, Indianapolis-based biotechnology company focused on the discovery and development of next-generation, protein-based biomarkers. Lonergan Partners was founded in 2001 and focuses on the recruitment of top executives for technology companies.